Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

Share Price is delayed by 15 minutes
Get Live Data
0.165    0.00 (0.00%)
Bid:
0.15
Ask:
0.18
Spread: 0.03 (20.00%)
Market Cap: £7.08m
OBD Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biodyn Share Chart

Holding(s) in Company

5 Feb 2025 14:11

RNS Number : 0570W
Oxford BioDynamics PLC
05 February 2025
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biodynamics plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Unicorn Asset Management Limited

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Unicorn AIM VCT plc

City and country of registered office (if applicable)

Teignmouth, Devon, United Kingdom

5. Date on which the threshold was crossed or reachedvi:

03 February 2025

6. Date on which issuer notified (DD/MM/YYYY):

05 February 2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

23.00%

23.00%

145,131,526

Position of previous notification (if

applicable)

7.94%

7.94%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares GB00BD5H8572

145,131,526

23.00%

SUBTOTAL 8. A

145,131,526

23.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Figures are based on total voting rights of 630,919,226

 

Place of completion

Unicorn Asset Management Limited, Preachers Court, Charterhouse, Charterhouse Square, London, EC1M 6AU

Date of completion

05 February 2025

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALASEENSEFA
Date   Source Headline
25th Jan 202211:44 amRNSPDMR Dealing
25th Jan 20227:00 amRNSFinal Results
19th Jan 20229:58 amRNSHolding(s) in Company
14th Jan 20222:36 pmRNSHolding(s) in Company
14th Jan 20227:00 amRNSHolding(s) in Company
13th Jan 202212:00 pmRNSHolding(s) in Company
11th Jan 20229:00 amRNSHolding(s) in Company
10th Jan 20227:02 amRNSHolding(s) in Company
4th Jan 20227:00 amRNSHolding(s) in Company
29th Dec 20214:00 pmRNSHolding(s) in Company
24th Dec 202111:40 amRNSPDMR Dealing
23rd Dec 20217:00 amRNSNotice of Results
17th Dec 20217:00 amRNSOBD updates on EpiSwitch CST and CiRT tests
13th Dec 20212:23 pmRNSHolding(s) in Company
13th Dec 202110:12 amRNSPDMR Dealing
1st Dec 202112:00 pmRNSPDMR Dealing
24th Nov 20213:02 pmRNSPDMR Dealing
22nd Nov 202111:00 amRNSPDMR Dealing
18th Nov 20213:16 pmRNSHolding(s) in Company
18th Nov 20213:10 pmRNSPDMR Dealing
18th Nov 202111:53 amRNSHolding(s) in Company
11th Nov 202111:08 amRNSResults of General Meeting
4th Nov 20217:00 amRNSHolding(s) in Company
2nd Nov 202112:22 pmRNSHolding(s) in Company
1st Nov 202112:43 pmRNSTotal Voting Rights
1st Nov 20217:00 amRNSHolding(s) in Company
25th Oct 20212:45 pmRNSOBD raises £3.62 million
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSChange of Registered Office
31st Aug 20217:00 amRNSOxford BioDynamics awarded US FNIH Grant
15th Jun 20211:06 pmRNSPDMR Dealing
15th Jun 20217:00 amRNSHalf-year Report
27th May 20219:00 amRNSNotice of Results
14th May 202110:17 amRNSPDMR Dealing / Grant of Share Options
28th Apr 20212:24 pmRNSHolding(s) in Company
9th Apr 20217:00 amRNSNew UK facilities to support expanded strategy
31st Mar 20217:00 amRNSOBD signs agreement with Agilent Technologies
24th Mar 202112:46 pmRNSResult of AGM
23rd Mar 20217:00 amRNSUS launch of EpiSwitch® COVID-19 Severity Test
17th Mar 20219:53 amRNSResults published of biomarker discovery program
23rd Feb 20211:36 pmRNSPublication of 2020 Annual Report and AGM date
28th Jan 20217:00 amRNSFinal Results
12th Jan 20217:00 amRNSNotice of Results
30th Dec 20207:00 amRNSDirectorate Change
15th Dec 20207:00 amRNSOxford BioDynamics to expand strategic focus
14th Dec 20207:00 amRNSAppointment of Chairman
2nd Nov 20207:00 amRNSStrategic partnership with Boca Biolistics
28th Oct 20207:00 amRNSDisease severity program for COVID-19 advances
8th Jul 20207:00 amRNSPDMR Dealing / Grant of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.